title: Modern treatment modalities in anxiety.
abstract: Developments in the medical management of anxiety tend, over the last two decades, to have clustered around modifications to the early benzodiazepines. These developments have given the psychiatrist a wide range of options in terms of intensity and duration of action but have carried with them the range of penalties associated with the benzodiazepines as a group. These include among others addiction potential and a sometimes inappropriate level of sedation. The need has been for a new drug, unrelated to the benzodiazepines and which is more specifically orientated towards anxiety. Buspirone, it seems, may well be such a drug. This paper discusses the anxiety disorders, the drug management of anxiety, the problems associated with traditional anxiolytics and the recent availability of a new class of drug in this indication.
authors.affiliation: West-Ros-Park Mental Health Centre, Boston, Mass.
authors.forename: H L
authors.initials: HL
authors.lastname: Goldberg
mesh_terms: D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans
chemical_list: D002065:Buspirone